Bladder Cancer Treatment Drug Market to Attain $14.24 billion by 2034, with 14.1% CAGR | Fact.MR Report
July 23, 2024 06:30 ET
|
FACT.MR
Rockville, MD., July 23, 2024 (GLOBE NEWSWIRE) -- According to a new report published by Fact.MR, the global Bladder Cancer Treatment Drug Market is estimated to reach a value of US$ 3.79 billion in...
Announcing the 2nd Annual ImmunoBio Series Conference: A Nexus of Biomarker Insights and Immuno-Oncology Innovations (Germany, 14th-15th October 2024)
July 12, 2024 11:05 ET
|
Research and Markets
Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "2nd Annual ImmunoBio Series" conference has been added to ResearchAndMarkets.com's offering. Introducing the 2nd Annual ImmunoBio Series, a...
United States Ovarian Cancer Diagnostics Market Witnesses Notable Growth, Expected to Propel at a CAGR of 5.79% Through 2029 - Advancements in Imaging and Genetic Testing as Major Growth Drivers
July 10, 2024 04:06 ET
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "United States Ovarian Cancer Diagnostics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F" report has been added to ...
U.S. Liver Cancer Diagnostics Market Analysis Report 2024-2030, by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use and Region
June 14, 2024 04:09 ET
|
Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "U.S. Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use,...
Companion Diagnostics Market Anticipated To Grow At 12.5% CAGR, Reaching USD 26.0 Billion By 2033 | Dimension Market Research
June 10, 2024 10:24 ET
|
Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Companion Diagnostics Market size is expected to reach USD 9.0 billion by 2024 and is further anticipated to reach USD...
World Immuno-Oncology Diagnostics Market Forecasts Report 2024: The Disruption Dynamic, The Race for Biomarkers, The Next Five Years
May 28, 2024 09:06 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
Cancer Diagnostics Market Size to Reach USD 204.8 Billion By 2032, at 6.6% CAGR: Dimension Market Research
May 07, 2024 13:38 ET
|
Dimension Market Research
New York, May 07, 2024 (GLOBE NEWSWIRE) -- Overview The Global Cancer Diagnostics Market size was valued at USD 114.8 billion in 2023 and it is further anticipated to reach a market value of USD...
Cancer Diagnostic Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 846 Agreements Signed Since 2016
May 07, 2024 07:10 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Cancer Diagnostic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Cancer Diagnostic...
Global Cancer Diagnostics Market Set to Reach US$ 280.37 Billion by 2030 with Illumina, Abbott Laboratories, Thermo Fisher Scientific, QIAGEN, Roche, Pfizer, Koninklijke Philips,& bioMérieux Leading
April 19, 2024 05:17 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis" report...
Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market 2023-2032: Liquid Biopsy for Breast Cancer Diagnosis and Complete Automation of Next-Generation Techniques are the Key Trends
March 11, 2024 13:17 ET
|
Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market: Analysis and Forecast, 2023-2032" report has been added to ...